The estimated Net Worth of Charles R Bodner is at least $1.21 millió dollars as of 6 September 2019. Mr. Bodner owns over 3,143 units of Becton Dickinson & Co stock worth over $1,210,514 and over the last 6 years he sold BDX stock worth over $0. In addition, he makes $0 as Senior Vice President és Corporate Finance at Becton Dickinson & Co.
Charles has made over 4 trades of the Becton Dickinson & Co stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 3,143 units of BDX stock worth $423,456 on 6 September 2019.
The largest trade he's ever made was exercising 3,143 units of Becton Dickinson & Co stock on 6 September 2019 worth over $423,456. On average, Charles trades about 1,881 units every 49 days since 2018. As of 6 September 2019 he still owns at least 5,180 units of Becton Dickinson & Co stock.
You can see the complete history of Mr. Bodner stock trades at the bottom of the page.
Charles R. Bodner serves as Senior Vice President, Corporate Finance of the Company. Bodner brings over two decades of healthcare experience to his new role at Bioclinica. While at BD, he held leadership positions in both corporate and commercial finance, including leadership of value capture activities as part of the CareFusion acquisition. Prior to his time at BD, Bodner held positions of increasing responsibility at Sanofi, Schering-Plough, and AstraZeneca.
Charles Bodner is 47, he's been the Senior Vice President és Corporate Finance of Becton Dickinson & Co since 2019. There are 29 older and 5 younger executives at Becton Dickinson & Co. The oldest executive at Becton Dickinson & Co. is Marshall Larsen, 71, who is the Lead Independent Director.
Charles's mailing address filed with the SEC is C/O BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES, NJ, 07417.
Over the last 22 years, insiders at Becton Dickinson & Co have traded over $106,782,599 worth of Becton Dickinson & Co stock and bought 23,860 units worth $1,771,828 . The most active insiders traders include Edward J Ludwig, William M Brown és Vincent A Forlenza. On average, Becton Dickinson & Co executives and independent directors trade stock every 20 days with the average trade being worth of $4,349,205. The most recent stock trade was executed by Roland Goette on 14 August 2024, trading 5,295 units of BDX stock currently worth $701,799.
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.
Becton Dickinson & Co executives and other stock owners filed with the SEC include: